Back

Press Release: Nortem BioGroup IPO on the Paris Stock Exchange with 12.9 Million Euro Valuation

Paris, 27 September – Nortem BioGroup (EPA:MLBIO) (MLBIO.PA), the Andalusian food technology company, was listed today on Euronext Paris at a valuation of EUR 12.9 million and a price of EUR 5 per share

Following the traditional bell-ringing ceremony at the market’s headquarters in La Défense, the company floated 2,578,500 shares under the stock exchange symbol MLBIO.

José Luis Vázquez, CEO of Nortem, said: “Today is a historic day for Nortem and for food bio-innovation in Europe. Our listing on Euronext Paris provides us with a platform to expand our presence in global markets”.

Since its foundation, Nortem has generated sales of approximately EUR 7 million in the financial year 2022, mainly through Amazon (AMZN). With more than half a million customers, its main market is Europe.

With this listing, Nortem BioGroup is positioned to access new financing opportunities that will allow it to accelerate its growth and consolidate its leadership in the food bio-innovation sector.

Nortem BioGroup operates as a holding company and currently controls five different brands of organic products and materials: Nortembio, NaturalPharma Laboratories, Luxury & Grace, Ecodescalk and LG Health iSystems.

In addition, more than 30% of the company’s revenues are spent on research and development. These activities are carried out entirely in El Puerto de Santa María (Cádiz), where 20% of the company’s workforce is dedicated to the development of new processes and products.

Nortem BioGroup’s mission is to promote sustainable food choices, innovative supplements and smart probiotics. This is in line with the brand’s commitment to environmental protection and human health.

Euronext is the pan-European stock exchange, created to foster collaboration between the capital markets of the European Union. The platform includes exchanges in Paris, Oslo, Dublin, Milan, Brussels, Amsterdam, Lisbon and the London futures market.